T

Tonghua Dongbao Pharmaceuticals

184 employees

Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.

Investor insights

Sectors invested in

Medical2
Biotechnology1
Medical Device1
Health Care1
Sales1

Funding rounds participated in

$11M sweet spot round size

Most of their 2 investments are in rounds between $7.7M and $15M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical

Date founded

1985

Investments made

浙江凯立特医疗器械有限公司 raised $15M on April 14, 2017

Investors: Legend Capital and Tonghua Dongbao Pharmaceuticals

厦门特宝生物工程股份有限公司 raised $7.7M on December 28, 2015

Investors: Tonghua Dongbao Pharmaceuticals

FAQ